A Comprehensive Review on DNA Gyrase Inhibitors

Author(s): S.R. Chitra*, N. Ramalakshmi, Subramani Arunkumar, P. Manimegalai

Journal Name: Infectious Disorders - Drug Targets
Formerly Current Drug Targets - Infectious Disorders

Volume 20 , Issue 6 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

The newly emerging infectious organisms, the global crisis in antibiotic resistance, and the threat of bioterrorism create an urgent need to discover novel antimicrobial agents. In order to develop novel antimicrobial agents, the mechanism of infectious disease must be better understood. DNA Gyrase is a bacterial enzyme that plays an important role in the replication of DNA and transcription process. It is not present in higher eukaryotes making it a perfect target for developing new antibacterial agents. This review describes the role of DNA gyrase inhibitors in preventing various diseases. In this review, we outline the synthesis and pharmacological action of various novel DNA gyrase inhibitors. DNA gyrase inhibitors were used to treat tuberculosis, bacterial, fungal infections and malaria. DNA gyrase inhibitors mainly act by preventing the supercoiling of DNA strands.

Keywords: DNA gyrase inhibitors, docking, antibacterial, anticancer, antimalarial, fungal infections.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 6
Year: 2020
Published on: 20 January, 2021
Page: [765 - 777]
Pages: 13
DOI: 10.2174/1871526520666200102110235
Price: $65

Article Metrics

PDF: 27